Guangjun Jing
Impact in
- Oncology top 10%
- CAR-T cell therapy research
- Cell Biology top 10%
- Endoplasmic Reticulum Stress and Disease
Papers in
-
- Nuclear Structure and Function 4
- RNA Research and Splicing 3
- Retinoids in leukemia and cellular processes 2
- RNA Interference and Gene Delivery 2
- Oncology 6
- CAR-T cell therapy research 6
- Co-authors
- Sarah X. Zhang (3 shared papers)Joshua J. Wang (3 shared papers)Songlin Shi (8 shared papers)Kailin Xu (4 shared papers)Kunming Qi (4 shared papers)Zhenyu Li (4 shared papers)Wei Sang (4 shared papers)Junnian Zheng (4 shared papers)
- Journals
- Journal of Cellular Biochemistry (4 papers)Diagnostic Microbiology and Infectious Disease (1 paper)The Anatomical Record (1 paper)Experimental Hematology and Oncology (1 paper)Transplantation and Cellular Therapy (1 paper)
- Partner nations
- ChinaUnited StatesSwitzerland
In The Last Decade
Guangjun Jing
22 papers receiving 660 citations
Guangjun Jing's Hit Papers
Peers
Comparison fields: 5 of 75
- Oncology 242
- Cell Biology 117
- Immunology 99
- Ophthalmology 38
- Molecular Biology 223
Countries citing papers authored by Guangjun Jing
This map shows the geographic impact of Guangjun Jing's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guangjun Jing with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guangjun Jing more than expected).
Fields of papers citing papers by Guangjun Jing
This network shows the impact of papers produced by Guangjun Jing. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guangjun Jing. The network helps show where Guangjun Jing may publish in the future.
Co-authors
The 25 scholars most cited alongside Guangjun Jing, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 22 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 159 | |
| 2 | 2018 | 130 | |
| 3 | 2019 | 67 | |
| 4 | 2015 | 49 | |
| 5 | 2015 | 35 | |
| 6 | 2010 | 31 | |
| 7 | Safety and efficacy of CD33-targeted CAR-NK cell therapy for relapsed/refractory AML: preclinical evaluation and phase I trial Hit paper breakdown → | 2025 | 26 |
| 8 | 2010 | 23 | |
| 9 | 2010 | 19 | |
| 10 | 2023 | 17 | |
| 11 | 2014 | 15 | |
| 12 | 2019 | 14 | |
| 13 | 2022 | 13 | |
| 14 | 2020 | 13 | |
| 15 | 2010 | 12 | |
| 16 | 2011 | 9 | |
| 17 | 2009 | 8 | |
| 18 | 2010 | 7 | |
| 19 | 2010 | 7 | |
| 20 | 2020 | 7 |
About Guangjun Jing
Guangjun Jing is a scholar working on Molecular Biology, Oncology, Cell Biology, Genetics and Immunology, having authored 22 papers that have together received 668 indexed citations. Recurring topics across this work include CAR-T cell therapy research (6 papers), Nuclear Structure and Function (4 papers), Endoplasmic Reticulum Stress and Disease (3 papers), RNA Research and Splicing (3 papers), Virus-based gene therapy research (3 papers), Retinoids in leukemia and cellular processes (2 papers), RNA Interference and Gene Delivery (2 papers) and Neuroblastoma Research and Treatments (2 papers). The work is most often cited by research in Oncology (242 citations), Cell Biology (117 citations), Immunology (99 citations), Ophthalmology (38 citations) and Molecular Biology (223 citations). Guangjun Jing has collaborated with scholars based in China, United States and Switzerland. Frequent co-authors include Sarah X. Zhang, Joshua J. Wang, Songlin Shi, Kailin Xu, Kunming Qi, Zhenyu Li, Wei Sang, Junnian Zheng, Bin Pan and Ming Shi. Their work appears in journals such as Journal of Cellular Biochemistry, Diagnostic Microbiology and Infectious Disease, The Anatomical Record, Experimental Hematology and Oncology and Transplantation and Cellular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.